• Je něco špatně v tomto záznamu ?

Paclitaxel isomerisation in polymeric micelles based on hydrophobized hyaluronic acid

D. Smejkalová, K. Nešporová, M. Hermannová, G. Huerta-Angeles, D. Cožíková, L. Vištejnová, B. Safránková, J. Novotný, J. Kučerík, V. Velebný,

. 2014 ; 466 (1-2) : 147-55.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008205

Physical and chemical structure of paclitaxel (PTX) was studied after its incorporation into polymeric micelles made of hyaluronic acid (HA) (Mw=15 kDa) grafted with C6 or C18:1 acyl chains. PTX was physically incorporated into the micellar core by solvent evaporation technique. Maximum loading capacity for HAC6 and HAC18:1 was determined to be 2 and 14 wt.%, respectively. The loading efficiency was higher for HAC18:1 and reached 70%. Independently of the derivative, loaded HA micelles had spherical size of approximately 60-80 nm and demonstrated slow and sustained release of PTX in vitro. PTX largely changed its form from crystalline to amorphous after its incorporation into the micelle's interior. This transformation increased PTX sensitivity towards stressing conditions, mainly to UV light exposure, during which the structure of amorphous PTX isomerized and formed C3C11 bond within its structure. In vitro cytotoxicity assay revealed that polymeric micelles loaded with PTX isomer had higher cytotoxic effect to normal human dermal fibroblasts (NHDF) and human colon carcinoma cells (HCT-116) than the same micelles loaded with non-isomerized PTX. Further observation indicated that PTX isomer influenced in different ways cell morphology and markers of cell cycle. Taken together, PTX isomer loaded in nanocarrier systems may have improved anticancer activity in vivo than pure PTX.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008205
003      
CZ-PrNML
005      
20171106142926.0
007      
ta
008      
150306s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2014.03.024 $2 doi
035    __
$a (PubMed)24614580
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Smejkalová, Daniela $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic. Electronic address: daniela.smejkalova@contipro.com.
245    10
$a Paclitaxel isomerisation in polymeric micelles based on hydrophobized hyaluronic acid / $c D. Smejkalová, K. Nešporová, M. Hermannová, G. Huerta-Angeles, D. Cožíková, L. Vištejnová, B. Safránková, J. Novotný, J. Kučerík, V. Velebný,
520    9_
$a Physical and chemical structure of paclitaxel (PTX) was studied after its incorporation into polymeric micelles made of hyaluronic acid (HA) (Mw=15 kDa) grafted with C6 or C18:1 acyl chains. PTX was physically incorporated into the micellar core by solvent evaporation technique. Maximum loading capacity for HAC6 and HAC18:1 was determined to be 2 and 14 wt.%, respectively. The loading efficiency was higher for HAC18:1 and reached 70%. Independently of the derivative, loaded HA micelles had spherical size of approximately 60-80 nm and demonstrated slow and sustained release of PTX in vitro. PTX largely changed its form from crystalline to amorphous after its incorporation into the micelle's interior. This transformation increased PTX sensitivity towards stressing conditions, mainly to UV light exposure, during which the structure of amorphous PTX isomerized and formed C3C11 bond within its structure. In vitro cytotoxicity assay revealed that polymeric micelles loaded with PTX isomer had higher cytotoxic effect to normal human dermal fibroblasts (NHDF) and human colon carcinoma cells (HCT-116) than the same micelles loaded with non-isomerized PTX. Further observation indicated that PTX isomer influenced in different ways cell morphology and markers of cell cycle. Taken together, PTX isomer loaded in nanocarrier systems may have improved anticancer activity in vivo than pure PTX.
650    _2
$a antitumorózní látky fytogenní $x aplikace a dávkování $x chemie $7 D000972
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a kultivované buňky $7 D002478
650    _2
$a nosiče léků $x aplikace a dávkování $x chemie $7 D004337
650    _2
$a fibroblasty $x účinky léků $7 D005347
650    _2
$a HCT116 buňky $7 D045325
650    _2
$a lidé $7 D006801
650    _2
$a kyselina hyaluronová $x aplikace a dávkování $x chemie $7 D006820
650    _2
$a hydrofobní a hydrofilní interakce $7 D057927
650    _2
$a isomerie $7 D007536
650    12
$a micely $7 D008823
650    _2
$a paclitaxel $x aplikace a dávkování $x chemie $7 D017239
650    _2
$a polymery $x aplikace a dávkování $x chemie $7 D011108
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nešporová, Kristina $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Hermannová, Martina $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Huerta-Angeles, Gloria $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Cožíková, Dagmar $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Vištejnová, Lucie $7 xx0218318 $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Safránková, Barbora $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Novotný, Jaroslav $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Kučerík, Jiří $u University of Koblenz-Landau, Campus Landau, Institute for Environmental Sciences, Fortstraße 7, 768 29, Landau, Germany.
700    1_
$a Velebný, Vladimír $u Contipro Pharma, Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 466, č. 1-2 (2014), s. 147-55
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24614580 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20171106143024 $b ABA008
999    __
$a ok $b bmc $g 1065478 $s 891005
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 466 $c 1-2 $d 147-55 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...